Cargando…

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care

BACKGROUND: Screening of primary care patients at risk for left ventricular systolic dysfunction by a simple blood-test might reduce referral rates for echocardiography. Whether or not natriuretic peptide testing is a useful and cost-effective diagnostic instrument in primary care settings, however,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koschack, Janka, Scherer, Martin, Lüers, Claus, Kochen, Michael M, Wetzel, Dirk, Kleta, Sibylle, Pouwels, Claudia, Wachter, Rolf, Herrmann-Lingen, Christoph, Pieske, Burkert, Binder, Lutz
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267193/ https://www.ncbi.nlm.nih.gov/pubmed/18298821 http://dx.doi.org/10.1186/1471-2296-9-14

Ejemplares similares

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Changes in heart failure medications in patients hospitalised and discharged
por: Scherer, Martin, et al.
Publicado: (2006)

Psychosocial determinants for frequent primary health care utilisation in patients with heart failure
por: Scherer, Martin, et al.
Publicado: (2008)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2010)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

Erratum to: Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2011)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure
por: Sadlonova, Monika, et al.
Publicado: (2020)

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
por: Wilke, Marieke R., et al.
Publicado: (2023)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Sensitivity to change of the Neck Pain and Disability Scale
por: Blozik, Eva, et al.
Publicado: (2010)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Psychometric properties of a German version of the neck pain and disability scale
por: Scherer, Martin, et al.
Publicado: (2008)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Depression and anxiety as major determinants of neck pain: a cross-sectional study in general practice
por: Blozik, Eva, et al.
Publicado: (2009)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)

Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function
por: GONG, HUI, et al.
Publicado: (2014)

B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle
por: Hegarova, Marketa, et al.
Publicado: (2016)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure
por: Gaborit, F, et al.
Publicado: (2015)

Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta‐analysis
por: Goyder, Clare R., et al.
Publicado: (2023)

Late onset apical hypertrophic cardiomyopathy: a case report
por: Doeblin, Patrick, et al.
Publicado: (2020)

N-terminal Pro-Brain Natriuretic Peptide Levels Predict Left Ventricular Systolic Function in Patients with Chronic Kidney Disease
por: Lee, Jung Eun, et al.
Publicado: (2009)

Elevated N-terminal pro-B-type natriuretic peptide levels and normal left ventricular systolic function: an echocardiographic study
por: Turley, A, et al.
Publicado: (2005)

N-terminal pro-B-type natriuretic peptide and the diagnosis of left ventricular systolic dysfunction: what is the optimal cut-off?
por: Turley, A, et al.
Publicado: (2005)

Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study
por: Schertz, Anna, et al.
Publicado: (2019)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function
por: Yen, Chih-Hsuan, et al.
Publicado: (2017)

Heart rate modulates the relationship of augmented systolic blood pressure with the blood natriuretic peptide levels
por: Tomiyama, Hirofumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9fa24ouhlc64h4i62o8dgj8dmj